ES8800267A1 - Un metodo para obtener un peptido biologicamente activo que tiene afinidad para un ligando proteinaceo o su receptor - Google Patents

Un metodo para obtener un peptido biologicamente activo que tiene afinidad para un ligando proteinaceo o su receptor

Info

Publication number
ES8800267A1
ES8800267A1 ES557189A ES557189A ES8800267A1 ES 8800267 A1 ES8800267 A1 ES 8800267A1 ES 557189 A ES557189 A ES 557189A ES 557189 A ES557189 A ES 557189A ES 8800267 A1 ES8800267 A1 ES 8800267A1
Authority
ES
Spain
Prior art keywords
peptides
proteins
amino acid
methods
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557189A
Other languages
English (en)
Other versions
ES557189A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/708,001 external-priority patent/US4863857A/en
Application filed by University of Texas System filed Critical University of Texas System
Publication of ES8800267A1 publication Critical patent/ES8800267A1/es
Publication of ES557189A0 publication Critical patent/ES557189A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/803Physical recovery methods, e.g. chromatography, grinding

Abstract

METODO DE PREPARAR UN PEPTIDO BIOLOGICAMENTE ACTIVO QUE TIENE AFINIDAD PARA UN LIGANDO PROTEINACEO O SU RECEPTOR. COMPRENDE: A) AVERIGUAR UNA SEGUNDA SECUENCIA DE NUCLEOTIDOS DE UNA SEGUNDA CADENA DE NUCLEOTIDOS QUE TIENE UN APAREAMIENTO DE BASE CON UNA PRIMERA CADENA DE NUCLEOTIDOS QUE CODIFICA UNA PORCION DE COMPONENTE PROTENACEO DE UN LIGANDO PEPTIDO; B) DETERMINAR EN EL LIGANDO PEPTIDICO EN CASO DE APAREAMIENTO DE LA SEGUNDA SECUENCIA DE NUCLEOTIDOS CON LA SECUENCIA DE NUCLEOTIDOS DEL LIGANDO, LAS SECUENCIAS DE AMINOACIDOS HOMOLOGAS A LAS SECUENCIAS DE AMINOACIDOS CODIFICADOS POR LOS NUCLEOTICOS; Y C) PREPARAR UN POLIPEPTIDO CON UNA PORCION DE LAS SECUENCIAS HOMOLOGADAS. SE UTILIZA PARA FABRICAR PENICILINAS SINTETICAS. A
ES557189A 1985-03-01 1986-11-03 Un metodo para obtener un peptido biologicamente activo que tiene afinidad para un ligando proteinaceo o su receptor Expired ES8800267A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/708,001 US4863857A (en) 1985-03-01 1985-03-01 Polypeptide complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
US06/829,709 US5077195A (en) 1985-03-01 1986-02-19 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor

Publications (2)

Publication Number Publication Date
ES8800267A1 true ES8800267A1 (es) 1987-11-01
ES557189A0 ES557189A0 (es) 1987-11-01

Family

ID=27108003

Family Applications (3)

Application Number Title Priority Date Filing Date
ES552534A Expired ES8705919A1 (es) 1985-03-01 1986-02-28 Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original.
ES557189A Expired ES8800267A1 (es) 1985-03-01 1986-11-03 Un metodo para obtener un peptido biologicamente activo que tiene afinidad para un ligando proteinaceo o su receptor
ES557188A Expired ES8800266A1 (es) 1985-03-01 1986-11-03 Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES552534A Expired ES8705919A1 (es) 1985-03-01 1986-02-28 Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557188A Expired ES8800266A1 (es) 1985-03-01 1986-11-03 Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original

Country Status (18)

Country Link
US (2) US5077195A (es)
EP (2) EP0332225B1 (es)
JP (1) JPH07215999A (es)
KR (1) KR920002315B1 (es)
AT (2) ATE88572T1 (es)
AU (1) AU592781B2 (es)
BR (1) BR8606615A (es)
CA (1) CA1339606C (es)
DE (2) DE3679017D1 (es)
DK (1) DK521386A (es)
ES (3) ES8705919A1 (es)
FI (1) FI90255C (es)
GR (1) GR860576B (es)
IE (1) IE58837B1 (es)
IL (1) IL96043A0 (es)
NO (1) NO174971C (es)
PT (1) PT82132B (es)
WO (1) WO1986005208A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592324B2 (en) * 1984-10-29 1990-01-11 Roche Diagnostics Corporation Mehods for protein binding enzyme complementation assays
DE3527568A1 (de) * 1985-08-01 1987-02-05 Bissendorf Peptide Gmbh Synthetische peptidrezeptoren, verfahren zur herstellung und verwendung derselben
CA1297003C (en) * 1985-09-20 1992-03-10 Jack H. Nunberg Composition and method for treating animals
EP0294390A1 (en) * 1986-02-19 1988-12-14 Triton Biosciences Inc. Peptides affecting blood pressure regulation
US4772684A (en) * 1987-01-20 1988-09-20 Triton Biosciences, Inc. Peptides affecting blood pressure regulation
JPH02104595A (ja) * 1988-03-04 1990-04-17 Univ Alabama 非ペプチドのペプチド相当物及びそのデザイン方法
DE69033395D1 (de) * 1989-07-31 2000-01-20 Tecnogen Scpa Verfahren zur Identifizierung und Herstellung von Bindungsstellen aufeinanderwirkender Proteine
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
JPH05262788A (ja) * 1991-09-03 1993-10-12 Hitachi Chem Co Ltd ペプチド類、その設計方法及び製造方法並びに受容体上の生理活性ペプチドの結合部位の決定方法
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
WO1995009643A1 (fr) * 1993-10-07 1995-04-13 Kurashiki Boseki Kk Inhibiteur de l'activite de l'endotheline
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
IL115177A0 (en) * 1994-09-16 1995-12-31 Immunomedics Inc Phosphorus-32 labeling of antibodies for cancer therapy
US5523208A (en) * 1994-11-30 1996-06-04 The Board Of Trustees Of The University Of Kentucky Method to discover genetic coding regions for complementary interacting proteins by scanning DNA sequence data banks
EP0835446B1 (en) 1995-06-26 2003-04-09 Perseptive Biosystems, Inc. High speed, automated, continuous flow, multi-dimensional molecular selection and analysis
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
DK1039931T3 (da) * 1997-12-01 2005-08-08 Fang Fang Multivalente rekombinante antistoffer til at behandle HRV infektioner
DE19805334A1 (de) * 1998-02-11 1999-08-12 Otogene Biotechnologische Fors Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes
EP1078099A4 (en) * 1998-04-24 2005-02-09 Fang Fang IDENTIFICATION OF PEPTIDE LIGANDS OF TARGET PROTEINS BY THE TECHNIQUE OF ADDITIONAL BANKS OF TCLT TARGETS
US20030035798A1 (en) * 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
EP1560590B1 (en) * 1999-03-09 2008-10-22 Fornix Biosciences N.V. Synthetic complementary peptides and ophthalmologic uses thereof
GB2356401A (en) 1999-11-19 2001-05-23 Proteom Ltd Method for manipulating protein or DNA sequence data
GB9929469D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from plant genomes
GB9929464D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligande generated from the human genome
GB9929466D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from microbial genome sequences
AU2001294822A1 (en) * 2000-09-26 2002-04-08 Geneformatics, Inc. Methods for determining aproximations of three dimensional polypeptide structure
GB0025251D0 (en) * 2000-10-14 2000-11-29 Proteom Ltd Antisense peptides to Fc receptors and their uses
DE60238308D1 (de) * 2001-02-20 2010-12-30 Univ Georgia Schnellproduktion monoklonaler antikörper
JP2005522192A (ja) * 2001-07-19 2005-07-28 パーラン セラピューティクス, インコーポレイテッド マルチマータンパク質およびマルチマータンパク質を作製および使用する方法
AU2008266120B2 (en) * 2007-06-14 2013-06-20 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
US8227583B2 (en) 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
WO2019046634A1 (en) * 2017-08-30 2019-03-07 Peption, LLC METHOD FOR GENERATING INTERACTIVE PEPTIDES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes

Also Published As

Publication number Publication date
IE58837B1 (en) 1993-11-17
ATE63138T1 (de) 1991-05-15
EP0332225A2 (en) 1989-09-13
EP0332225A3 (en) 1989-09-27
PT82132B (pt) 1989-05-31
FI90255C (fi) 1994-01-10
DK521386A (da) 1986-12-29
EP0214232B1 (en) 1991-05-02
KR920002315B1 (ko) 1992-03-21
NO174971C (no) 1994-08-10
CA1339606C (en) 1997-12-30
EP0332225B1 (en) 1993-04-21
ES8800266A1 (es) 1987-11-01
BR8606615A (pt) 1987-08-11
NO864369D0 (no) 1986-10-31
EP0214232A1 (en) 1987-03-18
NO864369L (no) 1987-01-02
DE3679017D1 (de) 1991-06-06
KR870700100A (ko) 1987-02-28
ES552534A0 (es) 1987-05-16
FI90255B (fi) 1993-09-30
NO174971B (no) 1994-05-02
DE3688333T2 (de) 1993-10-28
FI864427A0 (fi) 1986-10-30
GR860576B (en) 1986-07-01
WO1986005208A1 (en) 1986-09-12
DE3688333D1 (de) 1993-05-27
AU5510286A (en) 1986-09-24
PT82132A (en) 1986-04-01
FI864427A (fi) 1986-10-30
IL96043A0 (en) 1991-07-18
US5077195A (en) 1991-12-31
ES557189A0 (es) 1987-11-01
ES557188A0 (es) 1987-11-01
ES8705919A1 (es) 1987-05-16
JPH07215999A (ja) 1995-08-15
US5212072A (en) 1993-05-18
IE860527L (en) 1986-09-01
AU592781B2 (en) 1990-01-25
ATE88572T1 (de) 1993-05-15
DK521386D0 (da) 1986-10-31

Similar Documents

Publication Publication Date Title
ES8705919A1 (es) Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original.
ES2009590A6 (es) Metodo de preparacion de proteina de cadena pesada del factor tisular humano.
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
HK1041497A1 (en) Soluble receptor br43x2 and methods of using them for therapy
EP0150735A3 (en) Method and composition for preparation of factor viiic
ATE189684T1 (de) Rekombinante polypeptide und peptide, dafür kodierende nukleinsäuren und ihre verwendung in der tuberkulose-diagnose
ZA861482B (en) Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
GR3035099T3 (en) Corpuscles of stannius protein, stanniocalcin
Goto et al. Structural studies on stem bromelain isolation, characterization and alignment of the cyanogen bromide fragments
Fisher et al. Affinity labelling of the binding site of rabbit antibody. Evidence for the involvement of the hypervariable regions of the heavy chain
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
Barnett et al. Biological Sciences: Amino-acid Sequence of the Carboxyl Terminal Octapeptide of Human Haptoglobin β Chain
Roholt et al. A light chain tyrosyl sequence in the antibody site of a rabbit anti-p-azobenzoate antibody
Carrel et al. Studies on sheep anti-human IgG antibodies and their sub-units
IL96043A (en) Polypeptides having binding affinity for peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known,the binding affinity being dependent on the carboxy-terminal and amino-terminal directionality of the polypeptides
NZ606260A (en) Novel polypeptides involved in immune response

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980504